Biology Reference
In-Depth Information
of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem
273(48):31778-83.
32. Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, Maeda
N, Okumura K. (2005) Intracellular signaling for vasoconstrictor coupling factor 6: novel
function of beta-subunit of ATP synthase as receptor. Hypertension 46(5):1140-6.
33. Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, Sirato K, Magota K,
Kodama S, Okumura K. (2001) Mitochondrial coupling factor 6 as a potent endogenous
vasoconstrictor. J Clin Invest 108(7):1023-30.
34. Palczewski K, Kahn N, Hargrave PA. (1990) Nucleoside inhibitors of rhodopsin kinase.
Biochemistry 29(26):6276-82.
35. Quevillon S, Agou F, Robinson JC, Mirande M. (1997) The p43 component of the mammalian
multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating
polypeptide II cytokine. J Biol Chem 272(51):32573-9.
36. Saffer JD, Glazer RI. (1981) Inhibition of histone H1 phosphorylation by sangivamycin and
other pyrrolopyrimidine analogues. Mol Pharmacol 20(1):211-7.
37. Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M. (2008)
Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its
activity at the surface of neural cells. Mol Psychiatry 13(10):953-69.
38. Schwarz MA, Zheng H, Liu J, Corbett S, Schwarz RE. (2005) Endothelial-monocyte activat-
ing polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via
alpha5 beta1 integrin. Exp Cell Res 311(2):229-39.
39. Schwarz RE, Schwarz MA. (2004) In vivo therapy of local tumor progression by targeting
vascular endothelium with EMAP-II. J Surg Res 120(1):64-72.
40. Sprenger RR, Speijer D, Back JW, De Koster CG, Pannekoek H, Horrevoets AJ. (2004)
Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional
gel electrophoresis and mass spectrometry. Electrophoresis 25(1):156-72.
41. Veitonmaki N, Cao R, Wu LH, Moser TL, Li B, Pizzo SV, Zhivotovsky B, Cao Y. (2004)
Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for
k1-5-induced antiangiogenesis. Cancer Res 64(10):3679-86.
42. Wahl ML, Grant DS. (2000) Effects of microenvironmental extracellular pH and extracellu-
lar matrix proteins on angiostatin
s activity and on intracellular pH. Gen Pharmacol 35(5):
277-85.
43. Wahl ML, Kenan DJ, Gonzalez-Gronow M, Pizzo SV. (2005) Angiostatin's molecular
mechanism: aspects of specificity and regulation elucidated. J Cell Biochem 96(2):242-61.
44. Wahl ML, Owen CS, Grant DS. (2002) Angiostatin induces intracellular acidosis and anoikis
in endothelial cells at a tumor-like low pH. Endothelium 9(3):205-16.
45. Wang J, Han Y, Liang J, Cheng X, Yan L, Wang Y, Liu J, Luo G, Chen X, Zhao L, Zhou X,
Wu K, Fan D. (2008) Effect of a novel inhibitory mAb against beta-subunit of F1F0 ATPase
on HCC. Cancer Biol Ther 7(11):1829-35.
46. Wang T, Chen Z, Wang X, Shyy JY, Zhu Y. (2006) Cholesterol loading increases the transloca-
tion of ATP synthase beta chain into membrane caveolae in vascular endothelial cells. Biochim
Biophys Acta 1761(10):1182-90.
47. Watts SW. (2005) Vasoconstriction caused by the ATP synthase subunit-coupling factor 6: a
new function for a historical enzyme. Hypertension 46(5):1100-2.
48. Yamamoto K, Korenaga R, Kamiya A, Qi Z, Sokabe M, Ando J. (2000) P2X(4) receptors
mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart
Circ Physiol 279(1):H285-92.
49. Yamamoto K, Shimizu N, Obi S, Kumagaya S, Taketani Y, Kamiya A, Ando J. (2007)
Involvement of cell surface ATP synthase in flow-induced ATP release by vascular endothelial
cells. Am J Physiol Heart Circ Physiol 293(3):H1646-53.
50. Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato
T, Sekine K, Kato S, Isshiki M, Fujita T, Kobayashi M, Kawamura K, Masuda H, Kamiya A,
Search WWH ::
Custom Search